Vivani Medical Inc. VANI 深 沪
等待开盘 02-04 09:30:00 美东时间
1.40
-0.070
-4.76%
华盛通- 最 高1.49
- 今 开1.49
- 成交量 41.21万股
- 最 低 1.38
- 昨 收 1.47
- 总市值 1.02亿
- 52周最高 1.92
- 市盈率 静 --
- 换手率 0.56%
- 52周最低 0.9054
- 委 比 72.88%
- 总股本 7295.22万
- 历史最高 576.48
- 量 比 0.52
- 振 幅 7.48%
- 历史最低 0.7536
- 每 手 1
- 风险率 0.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vivani's Brain Implant Helps Blind Patients See Light And Movement In 6-Year Study
Vivani Medical, Inc. (NASDAQ:VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that Cortigent, Inc. ("Cortigent"), its
01-29 20:35
Cortigent Reports Promising Six-Year Results for Orion Visual Prosthesis
Cortigent Reports Promising Six-Year Results for Orion Visual Prosthesis Vivani Medical Inc. announced that its wholly-owned subsidiary, Cortigent, Inc., presented promising six-year early feasibility study results for the Orion® Visual Cortical Prosthesis System at the North American Neuromodulatio
01-29 20:30
Vivani Medical Director and 10% Owner Gregg Williams Reports Acquisition of Common Shares
Vivani Medical Director and 10% Owner Gregg Williams Reports Acquisition of Common Shares Gregg Williams, a Director and 10% Owner of Vivani Medical Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief
01-28 23:01
Vivani Medical Q3 EPS $(0.11), Inline
Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is unchanged from the same period last year.
2025-11-13 20:47
Vivani Medical Announces Company Presentation, Unveils Obesity Market Strategy With New GLP-1 Implant Technology
https://d1io3yog0oux5.cloudfront.net/_8b0e72ba9731939ad4ef3d445345826e/vivanimedical/db/2227/20875/pdf/Vivani+Corporate+Presentation+_+102925.pdf
2025-11-11 04:19
Vivani Medical Announces $15.7M Stock Offering
The latest update is out from Vivani Medical ( ($VANI) ). On October 26, 2025, ...
2025-10-28 18:28
Vivani Medical完成1600万美元募资
美股周一早盘，生物制药公司Vivani Medical（VANI）股价下跌5.9%，此前该公司宣布以每股1.62美元完成1600万美元募资，所筹资金将用于研...
2025-10-27 22:49
Vivani Medical prices $16M offering at $1.62 per share
Clinical-stage biopharmaceutical company Vivani Medical (NASDAQ:VANI) priced a registered direct offering of 6M shares of its common stock at an offering price of $1.62 per share and concurrent priv...
2025-10-27 15:11
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
Vivani Medical, Inc. announced the pricing of a registered direct offering of 6,000,000 shares and a concurrent private placement of 3,703,703 shares, each at $1.62, raising approximately $15.7 million. Proceeds will support research, clinical development, and working capital. The company focuses on developing ultra-long-acting drug implants for metabolic diseases, aiming to improve patient adherence and tolerance. ThinkEquity acted as the placem...
2025-10-26 23:15
Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025
Vivani Medical, Inc. announced that its CEO, Adam Mendelsohn, will present at the ThinkEquity Conference on October 30, 2025, in New York. The presentation will highlight the company's development of ultra-long-acting drug implants, particularly its GLP-1 based implants for metabolic diseases. A webcast of the presentation will be available on the company's website.
2025-10-22 12:30
